These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36412437)

  • 21. Tumor-Infiltrating Lymphocytes/Plasmocytes in Chemotherapeutically Non-Influenced Triple-Negative Breast Cancers - Correlation with Morphological and Clinico-Pathological Parameters.
    Kolečková M; Kolář Z; Ehrmann J; Kořínková G; Zlámalová N; Melichar B; Trojanec R
    Klin Onkol; 2019; 32(5):380-387. PubMed ID: 31610672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Value of Tumor Infiltrating Lymphocytes in Locally Advanced HER2 Enriched Breast Cancer.
    Saber MM; El Zawahry HM; Hilal AM; Abou-Bakr AA; Namour AE; Saber MM
    Asian Pac J Cancer Prev; 2022 Feb; 23(2):553-560. PubMed ID: 35225468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD10-positive stromal cells in gastric carcinoma: correlation with invasion and metastasis.
    Huang WB; Zhou XJ; Chen JY; Zhang LH; Meng K; Ma HH; Lu ZF
    Jpn J Clin Oncol; 2005 May; 35(5):245-50. PubMed ID: 15886270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [CD10 expression in stromal cells of patients with breast cancer: a poor prognostic marker].
    Bacha D; Amor AB; Farhat FB; Slama SB; Lahmar A; Bouraoui S; Triki A
    Pan Afr Med J; 2020; 37():70. PubMed ID: 33244333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD10 and E-cad expression in urinary bladder urothelial and squamous cell carcinoma.
    Omran OM
    J Environ Pathol Toxicol Oncol; 2012; 31(3):203-12. PubMed ID: 23339695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical analysis of tumor-infiltrating lymphocytes in breast carcinoma: relation to prognostic variables.
    Helal TE; Ibrahim EA; Alloub AI
    Indian J Pathol Microbiol; 2013; 56(2):89-93. PubMed ID: 24056641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation of CD117 immunoreactivity and microvascular density in invasive breast carcinoma.
    Amin MM; El-Hawary AK; Farouk O
    Indian J Pathol Microbiol; 2012; 55(4):456-60. PubMed ID: 23455779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of lymph node metastasis by tumor-infiltrating lymphocytes in T1 breast cancer.
    Takada K; Kashiwagi S; Asano Y; Goto W; Kouhashi R; Yabumoto A; Morisaki T; Shibutani M; Takashima T; Fujita H; Hirakawa K; Ohira M
    BMC Cancer; 2020 Jun; 20(1):598. PubMed ID: 32590956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study.
    Huang Y; Chen L; Tang Z; Min Y; Yu W; Yang G; Zhang L
    Front Endocrinol (Lausanne); 2021; 12():774244. PubMed ID: 34867821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunophenotypic profile of tumor infiltrating lymphocytes in medullary carcinoma of the breast.
    Tamiolakis D; Simopoulos C; Cheva A; Lambropoulou M; Kotini A; Jivannakis T; Papadopoulos N
    Eur J Gynaecol Oncol; 2002; 23(5):433-6. PubMed ID: 12440819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Tumor infiltrating lymphocytes in breast carcinoma and their correlation with molecular subtypes, tumor grade and stage.
    Pujani M; Jain H; Chauhan V; Agarwal C; Singh K; Singh M
    Breast Dis; 2020; 39(2):61-69. PubMed ID: 32310155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.
    Stenström J; Hedenfalk I; Hagerling C
    Breast Cancer Res; 2021 Feb; 23(1):27. PubMed ID: 33602289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic significance of B lymphocytes in invasive carcinoma of the breast.
    Mahmoud SM; Lee AH; Paish EC; Macmillan RD; Ellis IO; Green AR
    Breast Cancer Res Treat; 2012 Apr; 132(2):545-53. PubMed ID: 21671016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stromal expression of CD10 in breast carcinoma and its correlation with clinicopathological parameters.
    Dhande AN; Sinai Khandeparkar SG; Joshi AR; Kulkarni MM; Pandya N; Mohanapure N; Aggarwal A; Patil G
    South Asian J Cancer; 2019; 8(1):18-21. PubMed ID: 30766845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma.
    Valković T; Dobrila F; Melato M; Sasso F; Rizzardi C; Jonjić N
    Virchows Arch; 2002 Jun; 440(6):583-8. PubMed ID: 12070596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical/prognostic significance of Syndecan-1 expression in invasive breast carcinoma with distant metastasis and its correlation with tumor immunity.
    Wang H; Zhang Y; Yang Z; Jiang Y; Wu L; Wang R; Zhang Z
    Pathol Res Pract; 2023 Oct; 250():154787. PubMed ID: 37678063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer.
    Brodsky AS; Xiong J; Yang D; Schorl C; Fenton MA; Graves TA; Sikov WM; Resnick MB; Wang Y
    BMC Cancer; 2016 Apr; 16():274. PubMed ID: 27090210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stromal Expression of CD10 in Breast Carcinoma and Its Association with Known Prognostic Factors-A Tissue Microarray-Based Study.
    Gaffoor N; Krishnamurthy J
    J Lab Physicians; 2023 Sep; 15(3):354-360. PubMed ID: 37564218
    [No Abstract]   [Full Text] [Related]  

  • 40. Reduced PTEN expression is associated with poor outcome and angiogenesis in invasive ductal carcinoma of the breast.
    Lee JS; Kim HS; Kim YB; Lee MC; Park CS; Min KW
    Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):205-10. PubMed ID: 15551732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.